Skip to main content
. 2014 Dec 22;112(1):118–123. doi: 10.1073/pnas.1421839112

Fig. 4.

Fig. 4.

Relation between the number of rate-limiting driver mutations and the increase in CRC incidence observed in patients with MMR deficiency. The observed average increase in incidence associated with MMR deficiency is 114.2-fold (red line); the pink area is its 95% CI (60.7–217) (14). The expected increase in CRC incidence associated with the indicated number of rate-limiting mutations is represented by the blue marks, with the corresponding 95% CI indicated by blue vertical segments.